• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)与 REGARDS 研究中缺血性卒中的风险。

Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study.

机构信息

From the Division of Cardiology, Department of Medicine (P.A., G.A.), University of Alabama at Birmingham.

Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).

出版信息

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):810-818. doi: 10.1161/ATVBAHA.118.311857.

DOI:10.1161/ATVBAHA.118.311857
PMID:30786745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6511401/
Abstract

Objective- Increased Lp(a) [lipoprotein(a)] is associated with coronary heart disease risk, but links with stroke are less consistent. Blacks have higher Lp(a) levels and stroke incidence than whites but have been underrepresented in studies. We hypothesized that Lp(a) is a risk factor for ischemic stroke and that risk differs by race. Approach and Results- REGARDS (Reasons for Geographic and Racial Differences in Stroke) recruited 30 239 black and white US adults aged ≥45 in 2003-2007 to study regional and racial differences in stroke mortality. We measured baseline Lp(a) by immunonephelometric assay in 572 cases of incident ischemic stroke and a 967-person cohort random sample. The hazard ratio of stroke by baseline Lp(a) was calculated using Cox proportional hazards models, stratified by race. Lp(a) was modeled in sex- and race-specific quartiles, given known differences in distributions by race and sex. Interactions were tested by including interaction terms in the proportional hazards models, with P<0.10 considered statistically significant. After adjustment for age, sex, and stroke risk factors, being in the fourth versus the first Lp(a) quartile was weakly associated with ischemic stroke overall, hazard ratio, 1.45 (95% CI, 0.96-2.19). In blacks, the hazard ratio was 1.96 (95% CI, 1.10-3.46), whereas in whites HR was 1.14 (95% CI, 0.64-2.04); P interaction=0.12. Lp(a) was lower in men than women, but associations with stroke in men and women were similar. Conclusions- We confirm that Lp(a) is a risk factor for ischemic stroke. Further research is needed to confirm the role of racial differences of the Lp(a) risk multiplier in ischemic stroke.

摘要

目的

脂蛋白(a)[Lp(a)]升高与冠心病风险相关,但与中风的关联则不太一致。黑人的 Lp(a)水平和中风发病率高于白人,但在研究中代表性不足。我们假设 Lp(a)是缺血性中风的一个危险因素,且风险因种族而异。

方法和结果

REGARDS(中风地域和种族差异原因)研究于 2003 年至 2007 年招募了 30239 名年龄≥45 岁的美国黑人和白人成年人,以研究中风死亡率的地域和种族差异。我们使用免疫比浊法在 572 例新发缺血性中风病例和 967 人的队列随机样本中测量了基线 Lp(a)。使用 Cox 比例风险模型计算了按基线 Lp(a)分层的中风风险比。考虑到种族和性别分布的已知差异,按性别和种族特异性四分位数对 Lp(a)进行建模。通过在比例风险模型中包含交互项来检验交互作用,统计学显著性定义为 P<0.10。在校正年龄、性别和中风危险因素后,与处于 Lp(a)四分位第 1 位相比,处于第 4 位与缺血性中风总体相关,风险比为 1.45(95%CI,0.96-2.19)。在黑人中,风险比为 1.96(95%CI,1.10-3.46),而在白人中 HR 为 1.14(95%CI,0.64-2.04);P 交互=0.12。男性的 Lp(a)水平低于女性,但男性和女性的中风与 Lp(a)的关联相似。

结论

我们证实 Lp(a)是缺血性中风的一个危险因素。需要进一步的研究来证实 Lp(a)风险倍增器的种族差异在缺血性中风中的作用。

相似文献

1
Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study.脂蛋白(a)与 REGARDS 研究中缺血性卒中的风险。
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):810-818. doi: 10.1161/ATVBAHA.118.311857.
2
Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.脂蛋白(a)与缺血性卒中新发风险:社区动脉粥样硬化风险(ARIC)研究
Stroke. 2006 Jun;37(6):1407-12. doi: 10.1161/01.STR.0000222666.21482.b6. Epub 2006 May 4.
3
Stroke incidence and mortality trends in US communities, 1987 to 2011.美国社区 1987 至 2011 年的中风发病率和死亡率趋势。
JAMA. 2014 Jul 16;312(3):259-68. doi: 10.1001/jama.2014.7692.
4
Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors.性别和种族差异与缺血性卒中事件的危险因素的相关性。
JAMA Neurol. 2019 Feb 1;76(2):179-186. doi: 10.1001/jamaneurol.2018.3862.
5
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.凝血因子IX和XI水平与冠心病及缺血性中风发病的关联:REGARDS研究
J Thromb Haemost. 2017 Jun;15(6):1086-1094. doi: 10.1111/jth.13698. Epub 2017 May 9.
6
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.脂蛋白(a)水平与房颤和缺血性卒中发病风险的相关性:ARIC 研究(社区动脉粥样硬化风险研究)。
J Am Heart Assoc. 2017 Dec 15;6(12):e007372. doi: 10.1161/JAHA.117.007372.
7
Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.种族是为冠心病风险评估设定脂蛋白(a)临界值时的一个关键变量:动脉粥样硬化多族裔研究。
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):996-1001. doi: 10.1161/ATVBAHA.114.304785. Epub 2015 Feb 19.
8
Association between urinary albumin excretion and coronary heart disease in black vs white adults.黑种人和白种成年人的尿白蛋白排泄与冠心病之间的关系。
JAMA. 2013 Aug 21;310(7):706-14. doi: 10.1001/jama.2013.8777.
9
Association of race and sex with risk of incident acute coronary heart disease events.种族和性别与急性冠状动脉心脏病事件发生风险的关系。
JAMA. 2012 Nov 7;308(17):1768-74. doi: 10.1001/jama.2012.14306.
10
Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study.北方曼哈顿研究中的中风发病率的种族和民族差异。
Stroke. 2020 Apr;51(4):1064-1069. doi: 10.1161/STROKEAHA.119.028806. Epub 2020 Feb 12.

引用本文的文献

1
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHADS-VASc-Biomarkers model.利用循环生物标志物改善心房颤动患者的卒中风险预测:CHADS-VASc-生物标志物模型
J Thromb Haemost. 2025 Aug 1. doi: 10.1016/j.jtha.2025.06.007.
2
RACIAL DISPARITIES IN STROKE AFFECTING BLACK AMERICANS.影响美国黑人的中风种族差异。
Trans Am Clin Climatol Assoc. 2025;135:23-31.
3
Demographics of lipoprotein(a) and stroke: The UK biobank.脂蛋白(a)与中风的人口统计学:英国生物银行
Am J Prev Cardiol. 2025 Jun 29;23:101055. doi: 10.1016/j.ajpc.2025.101055. eCollection 2025 Sep.
4
Lipoprotein(a) and panvascular disease.脂蛋白(a)与泛血管疾病。
Lipids Health Dis. 2025 May 24;24(1):186. doi: 10.1186/s12944-025-02600-y.
5
Elevated plasma concentrations of lipoprotein (a) are associated with cardiovascular diseases in patients with early-onset type 2 diabetes mellitus.血浆脂蛋白(a)浓度升高与早发型2型糖尿病患者的心血管疾病相关。
Front Endocrinol (Lausanne). 2025 Apr 30;16:1434745. doi: 10.3389/fendo.2025.1434745. eCollection 2025.
6
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications.脂蛋白(a)作为一种中风生物标志物:病理生理途径及治疗意义
J Clin Med. 2025 Apr 25;14(9):2990. doi: 10.3390/jcm14092990.
7
Patient Experience of Heart Disease with Elevated Lipoprotein(a): Views from a Patient, His Physician, and a Patient Association.脂蛋白(a)升高的心脏病患者体验:来自一位患者、其医生及一个患者协会的观点
Cardiol Ther. 2025 May 11. doi: 10.1007/s40119-025-00416-6.
8
Lipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical Subgroups.脂蛋白(a)与动脉粥样硬化性心血管疾病发生风险:高敏C反应蛋白的影响及人类临床亚组中的风险变异性
Nutrients. 2025 Apr 11;17(8):1324. doi: 10.3390/nu17081324.
9
Association of Lp(a) With Stroke and Cerebral Injury on MRI: Insights From the HCHS/SOL (Hispanic Community Health Study/Study of Latinos) and Investigation of Neurocognitive Aging MRI (SOL-INCA MRI).脂蛋白(a)与MRI所示中风及脑损伤的关联:来自西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)及神经认知老化MRI研究(SOL-INCA MRI)的见解
Stroke. 2025 Jun;56(6):1492-1504. doi: 10.1161/STROKEAHA.124.048439. Epub 2025 Apr 1.
10
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening.重新审视心血管风险:脂蛋白(a)筛查的新作用。
Am J Prev Cardiol. 2025 Feb 14;21:100945. doi: 10.1016/j.ajpc.2025.100945. eCollection 2025 Mar.

本文引用的文献

1
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2018 急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24.
2
Lipoprotein (a), an independent cardiovascular risk marker.脂蛋白(a),一种独立的心血管风险标志物。
Clin Diabetes Endocrinol. 2016 Mar 31;2:7. doi: 10.1186/s40842-016-0024-x. eCollection 2016.
3
A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.在语境中检验:脂蛋白(a):诊断、预后、争议和新兴疗法。
J Am Coll Cardiol. 2017 Feb 14;69(6):692-711. doi: 10.1016/j.jacc.2016.11.042.
4
LPA Gene, Ethnicity, and Cardiovascular Events.脂蛋白A基因、种族与心血管事件
Circulation. 2017 Jan 17;135(3):251-263. doi: 10.1161/CIRCULATIONAHA.116.024611. Epub 2016 Nov 9.
5
Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans.载脂蛋白(a)的反义抑制作用以降低人体血浆脂蛋白(a)水平。
J Lipid Res. 2016 Mar;57(3):340-51. doi: 10.1194/jlr.R052258. Epub 2015 Nov 4.
6
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.依洛尤单抗降低血脂和心血管事件的疗效和安全性。
N Engl J Med. 2015 Apr 16;372(16):1500-9. doi: 10.1056/NEJMoa1500858. Epub 2015 Mar 15.
7
Targeting lipoprotein (a): an evolving therapeutic landscape.靶向脂蛋白(a):不断演变的治疗前景。
Curr Atheroscler Rep. 2015 May;17(5):502. doi: 10.1007/s11883-015-0502-0.
8
Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.在一项没有实地中心的全国性观察队列研究中验证实验室结果:中风队列中地理和种族差异的原因。
Clin Biochem. 2014 Nov;47(16-17):243-6. doi: 10.1016/j.clinbiochem.2014.08.003. Epub 2014 Aug 14.
9
ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study.ABO血型与中风风险:中风地理和种族差异原因研究
J Thromb Haemost. 2014 Apr;12(4):564-70. doi: 10.1111/jth.12507.
10
Lipoprotein(a), cardiovascular disease, and contemporary management.脂蛋白(a)、心血管疾病和当代管理。
Mayo Clin Proc. 2013 Nov;88(11):1294-311. doi: 10.1016/j.mayocp.2013.09.003.